<DOC>
	<DOC>NCT01054170</DOC>
	<brief_summary>The primary objective of the study is to evaluate structural changes effected by AD9668 in the airways of adults with Chronic Obstructive Pulmonary Disease (COPD) by Multi-Slice Computed Tomography (MSCT)</brief_summary>
	<brief_title>Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>Diagnosis of COPD with symptoms over 1 year FEV1/FVC &lt; 70% and FEV1 &gt;= 40 and &lt; =70 % of predicted postbronchodilator Exsmokers for at least 12 months Past history or current evidence of clinically significant heart disease Current diagnosis of asthma Worsening of COPD requiring hospitalisation and/or treatment with antibiotics and/or an increase in inhaled steroid dose and/or oral steroids within 4 weeks of study visit 1b</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Chronic</keyword>
	<keyword>obstructive</keyword>
	<keyword>pulmonary</keyword>
	<keyword>lung</keyword>
	<keyword>respiratory disease</keyword>
	<keyword>efficacy</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>COPD</keyword>
	<keyword>FEV1</keyword>
	<keyword>St Georges Respiratory Questionnaire</keyword>
	<keyword>Computed Tomography</keyword>
	<keyword>MSCT</keyword>
</DOC>